Palo Alto Investors »

Crispr Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 41k 64.81
2025-06-30 $2.2M 45k 48.64